Peter Lawson

Stock Analyst at Barclays

(1.47)
# 3,507
Out of 5,044 analysts
100
Total ratings
41.86%
Success rate
-10.05%
Average return

Stocks Rated by Peter Lawson

BeOne Medicines AG
Sep 18, 2025
Initiates: Overweight
Price Target: $385
Current: $315.43
Upside: +22.06%
IDEAYA Biosciences
Sep 4, 2025
Initiates: Overweight
Price Target: $40
Current: $32.37
Upside: +23.57%
Schrödinger
Aug 14, 2025
Initiates: Overweight
Price Target: $25
Current: $22.17
Upside: +12.77%
Replimune Group
Jul 23, 2025
Downgrades: Equal-Weight
Price Target: $17$3
Current: $9.33
Upside: -67.85%
Exelixis
Jul 10, 2025
Maintains: Equal-Weight
Price Target: $29$40
Current: $39.99
Upside: +0.03%
MacroGenics
May 14, 2025
Maintains: Overweight
Price Target: $8$3
Current: $1.91
Upside: +57.07%
Fate Therapeutics
May 14, 2025
Maintains: Overweight
Price Target: $10$2
Current: $1.55
Upside: +29.03%
Adaptimmune Therapeutics
May 14, 2025
Maintains: Underweight
Price Target: $1$0.46
Current: $0.05
Upside: +737.89%
Karyopharm Therapeutics
May 13, 2025
Maintains: Overweight
Price Target: $5$10
Current: $6.42
Upside: +55.76%
Iovance Biotherapeutics
May 12, 2025
Maintains: Overweight
Price Target: $5$4
Current: $2.31
Upside: +73.16%
Maintains: Underweight
Price Target: $22$6
Current: $14.27
Upside: -57.95%
Maintains: Overweight
Price Target: $32$11
Current: $11.04
Upside: -0.36%
Maintains: Overweight
Price Target: $32$16
Current: $9.65
Upside: +65.80%
Maintains: Overweight
Price Target: $40$15
Current: $8.12
Upside: +84.73%
Maintains: Overweight
Price Target: $29$14
Current: $18.60
Upside: -24.73%
Maintains: Equal-Weight
Price Target: $11$3
Current: $1.42
Upside: +111.27%
Maintains: Overweight
Price Target: $14$3
Current: $2.28
Upside: +31.58%
Maintains: Overweight
Price Target: $9$4
Current: $1.28
Upside: +212.50%
Maintains: Overweight
Price Target: $54$60
Current: $57.99
Upside: +3.47%
Maintains: Overweight
Price Target: $14$17
Current: $7.38
Upside: +130.35%
Maintains: Overweight
Price Target: $32$33
Current: $13.11
Upside: +151.72%
Maintains: Overweight
Price Target: $92$66
Current: $33.46
Upside: +97.25%
Maintains: Overweight
Price Target: $20$31
Current: $11.98
Upside: +158.76%
Maintains: Overweight
Price Target: $18$13
Current: $7.77
Upside: +67.31%
Maintains: Equal-Weight
Price Target: $7$5
Current: $1.71
Upside: +192.40%
Maintains: Overweight
Price Target: $7$3.5
Current: $3.36
Upside: +4.17%
Maintains: Underweight
Price Target: $355$365
Current: $100.35
Upside: +263.73%
Upgrades: Overweight
Price Target: $46
Current: $43.08
Upside: +6.78%
Initiates: Overweight
Price Target: $450
Current: $62.57
Upside: +619.19%
Upgrades: Buy
Price Target: $17$45
Current: $3.25
Upside: +1,284.62%
Upgrades: Buy
Price Target: $16$45
Current: $65.72
Upside: -31.53%